Goldman Sachs Call 230 DVA 20.03..../ DE000GJ4AEQ2 /
20.12.2024 9:59:25 | Изменение-0.020 | Бид22:00:25 | Предложение22:00:25 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.560EUR | -3.45% | - Величина цены спроса: - |
- Величина цены предложения: - |
DaVita Inc | 230.00 USD | 20.03.2026 | Call |
GlobeNewswire
24.06
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
18.06
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
26.04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17.11.2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15.08.2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21.03.2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07.03.2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10.02.2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07.10.2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01.10.2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница